Wall Street Admits Curing Diseases Is Bad For Business

Big pharma, the media, and the government in a big smelly ménage de trois.

Rigged Game

If “human progress” has a bottom, this is probably it.

By Lee Camp and cross-posted from truthdig

Goldman Sachs has outdone itself this time. That’s saying a lot for an investment firm that both helped cause and then exploited a global economic meltdown, increasing its own wealth and power while helping to boot millions of Americans out of their homes.

But now Goldman Sachs is openly saying in financial reports that curing people of terrible diseases is not good for business.

I wish this were a joke. It sounds like a joke. In fact, I’ll show you later that it used to be one of my favorite jokes. But first, the facts.

In a recent report, a Goldman analyst asked clients: “Is curing patients a sustainable business model?” Salveen Richter wrote: “The potential to deliver ‘one-shot cures’ is one of the most attractive aspects of gene therapy…

View original post 283 more words

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s